Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage

Jake G Hoekstra1, Michael J Hipp1, Thomas J Montine2

  • 1Department of Pathology, University of Washington, Seattle, WA.

Annals of Neurology
|June 18, 2016
PubMed

Insights

Early Alzheimer disease (AD) shows increased mitochondrial DNA (mtDNA) mutations in the hippocampus. Ultrasensitive sequencing revealed these mutations stem from replication errors, not oxidative damage, offering new insights into AD pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mitochondrial dysfunction and oxidative damage are hallmarks of early Alzheimer disease (AD).
  • Somatic mutations in mitochondrial DNA (mtDNA) are suspected contributors, but sensitive detection methods were lacking.
  • Understanding mtDNA mutation dynamics is crucial for elucidating AD's early mechanisms.

Purpose of the Study:

  • To quantify the mutation load across the entire mitochondrial genome in early-stage AD.
  • To investigate the underlying causes of mtDNA mutations in the AD hippocampus.
  • To assess the role of replication errors versus oxidative damage in AD-related mtDNA mutations.

Main Methods:

  • Employed an ultrasensitive next-generation sequencing (NGS) technique for comprehensive mitochondrial genome analysis.
  • Measured the frequency and distribution of somatic mutations in mtDNA from hippocampal tissues.
  • Differentiated mutation origins by analyzing patterns consistent with replication errors or oxidative damage.

Main Results:

  • A significant increase in mtDNA mutation frequency was detected in the hippocampus of individuals with early-stage AD.
  • The observed mtDNA mutation patterns strongly indicated replication errors as the primary cause.
  • Evidence did not support oxidative damage as the main driver of these mutations in early AD.

Conclusions:

  • Early-stage Alzheimer disease is characterized by elevated mtDNA mutation rates in the hippocampus.
  • Replication errors, rather than oxidative damage, are the predominant source of these mutations.
  • These findings highlight the importance of mtDNA integrity and replication fidelity in AD pathogenesis.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
10.0K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
663